According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss ...

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

A Miami-Dade County woman was arrested for allegedly selling unlicensed weight-loss medications from her beauty business, ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...